Search results for "Highlights"
Spotlight on IBD therapy comparisons
Recent research on inflammatory bowel disease (IBD) therapies compared vedolizumab with anti-tumor necrosis factor therapy, risankizumab with ustekinumab for Crohn's disease, and upadacitinib with tofacitinib for ulcerative colitis.
https://gastroenterology.acponline.org/archives/2024/07/26/5.htm
26 Jul 2024
Early vs. late paracentesis associated with better outcomes in hospitalized cirrhosis patients
Patients hospitalized with cirrhosis and ascites who received diagnostic paracentesis within 12 to 24 hours of admission had lower rates of in-hospital mortality and acute kidney injury and shorter length of stay than those who received it later, a meta-analysis found.
https://gastroenterology.acponline.org/archives/2024/07/26/2.htm
26 Jul 2024
Subscribe
ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.
https://gastroenterology.acponline.org/subscribe/index.html
Clinical practice update advises on management of cyclic vomiting syndrome
A basic workup for episodic vomiting should include bloodwork and urinalysis, and management of cyclic vomiting syndrome often entails multiple abortive medications, the American Gastroenterological Association said.
https://gastroenterology.acponline.org/archives/2024/07/26/3.htm
26 Jul 2024
Acute gastroenteritis infection associated with later IBS, functional dyspepsia, review finds
Prevalence of irritable bowel disease and functional dyspepsia were 14.5% and 12.7%, respectively, in patients who had experienced acute gastroenteritis, a risk more than three times higher than that in uninfected patients.
https://gastroenterology.acponline.org/archives/2024/07/26/1.htm
26 Jul 2024
In the Clinic, 2023 summary highlight gastroenterology topics
Colorectal cancer screening was the focus of the latest In the Clinic article, while an article in a supplement to Annals reviewed clinically important developments in gastroenterology and hepatology in 2023.
https://gastroenterology.acponline.org/archives/2024/04/26/5.htm
26 Apr 2024
Colectomy linked with greater risk of AKI, kidney failure in patients with IBD
Among patients with inflammatory bowel disease (IBD), colectomy was linked with more than doubled risk of acute kidney injury (AKI), indicating that these patients may benefit from close monitoring of kidney biomarkers, according to the authors of a Swedish cohort study.
https://gastroenterology.acponline.org/archives/2024/05/24/3.htm
24 May 2024
Higher MAP linked with AKI reversal among hospitalized patients
A 5 mm Hg increase in mean arterial pressure (MAP) was linked with a small but significant increase in the likelihood of reversal of acute kidney injury (AKI), according to a retrospective study of patients hospitalized with decompensated cirrhosis.
https://gastroenterology.acponline.org/archives/2024/04/26/2.htm
26 Apr 2024
GLP-1 receptor agonists could modestly delay gastric emptying during periprocedural fasting, study suggests
A systematic review and meta-analysis found that glucagon-like peptide-1 (GLP-1) receptor agonists were associated with a delay of approximately 36 minutes in gastric emptying on scintigraphy compared to placebo.
https://gastroenterology.acponline.org/archives/2024/04/26/3.htm
26 Apr 2024
GLP-1s associated with lower risk of hepatic decompensation than other diabetes drugs
Patients taking glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes had lower risk of hepatocellular carcinoma than those on insulin or sulfonylureas, and hepatic decompensation risk was reduced compared with five comparison diabetes drug classes, a study found.
https://gastroenterology.acponline.org/archives/2024/05/24/2.htm
24 May 2024